EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Childhood Underweight and Adulthood Obesity Associated With Increased Risk of MASLD and Cirrhosis: A Prospective Cohort Study of 375,125 Adults

Jiadong Zeng, Jian Liang, Hao Zhang, Hanming Wang, zheyang Lin, Wenzhe Zhang, Haobin Zhang, Xudong Deng, Jiahui Lin, Minqi Liu, Minwen Chen, Yue Qiu, Zhen Zhang, Zhaohua Zhu, Yi Zeng

Hepatology Research · 2026-11 · 56 (11) · 1643-1653

DOI: 10.1111/hepr.70238 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Obesity is a known risk factor for metabolic dysfunction–associated steatotic liver disease (MASLD) and cirrhosis, but the long‐term effects of childhood thinness and body size changes across life are unclear. We aimed to assess how body size and child‐to‐adult body size trajectories relate to major liver outcomes. Methods We studied 375,125 UK Biobank participants without liver disease at baseline. Childhood body size (thinner, average, and plumper) and adulthood body size (normal, overweight, and obesity) were combined into nine trajectories. Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for incident MASLD and cirrhosis. Kaplan–Meier survival curves assessed the association between body size trajectories and liver diseases. Sensitivity and subgroup analyses tested robustness. Results Compared with average childhood body size, childhood thinness was associated with higher risks of MASLD (HR 1.18, 95% CI 1.11–1.27) and cirrhosis (HR 1.15, 95% CI 1.03–1.27). Relative to persistently normal body size, the “thinner to obesity” trajectory showed the greatest risks of MASLD (HR 3.95, 95% CI 3.29–4.76) and cirrhosis (HR 3.97, 95% CI 3.30–4.77). The “plumper to normal” trajectory was not associated with increased MASLD or cirrhosis. Conclusion Childhood thinness is associated with increased risks of MASLD and cirrhosis in adulthood. Achieving a normal BMI in adulthood may mitigate liver‐related risks linked to childhood overweight.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →